Stock SPEC INSPECS GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings INSPECS Group plc

Equities

SPEC

GB00BK6JPP03

Market Closed - London S.E.
Other stock markets
 11:35:01 2024-04-26 EDT 		5-day change 1st Jan Change
57 GBX +2.70% Intraday chart for INSPECS Group plc +8.57% -32.14%
04-17 AIM WINNERS & LOSERS: Inspecs confident but Scirocco eyes AIM exit AN
04-17 Inspecs hails "encouraging" recent trading after tepid start to 2024 AN

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation
  • The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.4 for the 2024 fiscal year.
  • The company has a low valuation given the cash flows generated by its activity.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
INSPECS GROUP PLC Stock INSPECS Group plc
-32.14% 72.18M
C-
ESSILORLUXOTTICA Stock EssilorLuxottica
+11.95% 98.12B
B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-6.10% 17.66B
B-
AUTEK CHINA INC. Stock Autek China Inc.
-20.02% 2.24B
D+
WARBY PARKER INC. Stock Warby Parker Inc.
-8.37% 1.54B
C+
PEGAVISION CORPORATION Stock Pegavision Corporation
+29.63% 1.23B -
MENICON CO., LTD. Stock Menicon Co., Ltd.
-35.36% 735M
B-
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-35.62% 747M -
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-13.36% 623M -
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+24.04% 494M - -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SPEC Stock
  4. Ratings INSPECS Group plc